跳到正文
原文
Medical Xpress·· 16 天前AI 评分41

年龄影响致幻剂使用与心理健康的关系

Age may influence links between psychedelic use and mental health

AI 导读

研究发现,经典致幻剂(如迷幻蘑菇和LSD)使用者在年轻时报告的焦虑和抑郁水平较低,但这种关联随年龄增长而减弱,老年群体中不再明显。该研究强调年龄是未来研究的重要因素,但未证明致幻剂使用与心理健康之间的因果关系。

正文
Age may influence links between psychedelic use and mental health
Age-related variation in anxiety and depression among classic and non-classic psychedelic users. Credit: Scientific Reports (2026). DOI: 10.1038/s41598-026-68283-2

Age could play an important role in how psychedelic use relates to mental health, according to new research from the Department of Psychology at Durham University. Researchers found that adults with a history of using classic psychedelics, such as psilocybin (magic mushrooms) and LSD, reported lower levels of anxiety and depression than nonusers, but only in younger age groups. The associations became weaker with increasing age and were no longer evident among older adults.

The research comes amid growing scientific interest in the potential of psychedelic-assisted therapies for mental health conditions such as depression and anxiety.

Important factor to explore

The study, led by Ph.D. researcher Giammarco Di Gregorio under the supervision of Dr. Marco Bocchio and Dr. Michael Lengieza, is published in Scientific Reports.

The team analyzed survey responses from 1,088 adults aged 18 to 55 and older. Participants were asked about their lifetime use of psychedelic substances and completed established measures of anxiety, depression, well-being and life satisfaction.

The researchers stress that the findings do not establish a causal relationship between psychedelic use and mental health. Instead, it identifies an association between lifetime psychedelic use and current mental health, while highlighting age as an important factor that should be explored in future research.

Age-related association

To gather their results, the researchers grouped participants according to whether they had used classic psychedelics, nonclassic psychedelics such as ketamine or MDMA, a combination of both, or neither.

They found that people in their 20s and early 30s who had used classic psychedelics reported lower anxiety and depression scores than comparable nonusers. The association gradually declined with age.

The findings remained even after researchers accounted for factors such as how often people used psychedelics, when they last used them and their typical dosage.

Further investigation

Researchers believe these findings could help guide future clinical studies exploring psychedelic-assisted therapies. They say age should be considered when assessing who may benefit most from such treatments.

The study was observational and relied on participants reporting their own experiences. Because of this, the researchers cannot determine whether psychedelic use directly led to differences in mental health.

The team now hopes to build on the work through longer-term studies that track people before and after psychedelic experiences. This could help researchers better understand how age influences outcomes over time and whether the patterns seen in this study are also present in clinical settings.

Publication details

Giammarco Di Gregorio et al., Age moderates the relationship between psychedelic use and mental health in naturalistic settings, Scientific Reports (2026). DOI: 10.1038/s41598-026-68283-2

Journal information: Scientific Reports

Key medical concepts

Anxiety

Who's behind this story?

Lisa Lock

Lisa Lock

BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Age may influence links between psychedelic use and mental health (2026, November 4) retrieved 4 November 2026 from https://medicalxpress.com/news/2026-11-age-links-psychedelic-mental-health.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com